OmniAb (OABI) Change in Accured Expenses (2021 - 2026)
OmniAb's (OABI) quarterly Change in Accured Expenses came in at -$2.5 million in Q1 2026, up 15.03% year-on-year from -$2.2 million in Q1 2025, and down 300.16% on a QoQ basis from $1.3 million in Q4 2025.
OmniAb (OABI) Change in Accured Expenses (2021 - 2026) Analysis & Trends
OmniAb (OABI) has 6 years of Change in Accured Expenses data on file, last reported at -$2.5 million in Q1 2026.
- On a quarterly basis, Change in Accured Expenses rose 15.03% year-over-year to -$2.5 million in Q1 2026; TTM through Mar 2026 was $215000.0, a 111.0% increase from a year earlier, with the FY2025 full-year figure at -$231000.0, up 90.41% from the prior year.
- Change in Accured Expenses for Q1 2026 stood at -$2.5 million, down from $1.3 million in the prior quarter.
- Over the last five years, Change in Accured Expenses for OABI reached as high as $14.6 million in Q4 2022 and fell as low as -$3.4 million in Q1 2024.
- Historically, Change in Accured Expenses has averaged $636764.7 across 5 years, with a median of $280000.0 in 2025.
- Across the five-year window, Change in Accured Expenses soared 2257.45% in 2023 and slumped 114.8% in 2024, its largest moves.
- Year by year, Change in Accured Expenses stood at $14.6 million in 2022, then tumbled by 103.59% to -$526000.0 in 2023, then surged by 247.53% to $776000.0 in 2024, then jumped by 62.37% to $1.3 million in 2025, then plunged by 300.16% to -$2.5 million in 2026.
- Per Business Quant data, the three most recent Change in Accured Expenses figures were -$2.5 million in Q1 2026, $1.3 million in Q4 2025, and $280000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 1.13 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 931,000.00 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -16.82 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 23.10 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 107.70 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -16.74 Mn |
| 10 | OmniAb | 260.98 Mn | 211.91 Mn | 14.41 Mn | -2.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.52 Mn |
| Mar 31, 2026 | -2.52 Mn |
| Dec 31, 2025 | 1.26 Mn |
| Dec 31, 2025 | 1.26 Mn |
| Sep 30, 2025 | 280,000.00 |
| Sep 30, 2025 | 280,000.00 |
| Jun 30, 2025 | 1.20 Mn |
| Jun 30, 2025 | 1.20 Mn |
| Mar 31, 2025 | -2.97 Mn |
| Mar 31, 2025 | -2.97 Mn |
| Dec 31, 2024 | 776,000.00 |
| Dec 31, 2024 | 776,000.00 |
| Sep 30, 2024 | 402,000.00 |
| Sep 30, 2024 | 402,000.00 |
| Jun 30, 2024 | -164,000.00 |
| Jun 30, 2024 | -164,000.00 |
| Mar 31, 2024 | -3.42 Mn |
| Mar 31, 2024 | -3.42 Mn |
| Dec 31, 2023 | -526,000.00 |
| Dec 31, 2023 | -526,000.00 |